4.3 Article

Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

期刊

CURRENT DRUG METABOLISM
卷 14, 期 5, 页码 547-564

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389200211314050005

关键词

Nanotechnologies; nanoparticles; gene therapy; anticancer drugs; drug carriers; cancer; cytostatic; targeted therapy

资金

  1. Grant Agency of the Czech Republic [GACR 102/11/1068]
  2. project CEITEC - Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]
  3. project for conceptual development of research organization [00064203]

向作者/读者索取更多资源

This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy and summarizes advantages and disadvantages of each approach. Particularly, the attention was paid to polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles, and carbon nanotubes. Further, this paper briefly focuses on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin, and geldanamycin) and on the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据